Not logged inEfficacy and Safety of Efdamrofusp Alfa versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration A Randomized, Double-Masked, Active-Controlled, Noninferiority, Phase II Trial
Sun, Junran; Song, Yanping; Gong, Yuanyuan; Tao, Liming; Wang, Hong; Shu, Xiangwen; Wen, Ying; Cui, Ling; Ye, Jian; Lu, Shujie; Deng, Junjie; Li, Haoyu; Xu, Yihua; Qian, Lei; Wu, Zhifeng; Bi, Yanlong; Liu, Qinghuai; Xu, Xiangzhong; Wu, Miaoqin; Zhang, Jinglin; Hao, Jilong; Tong, Jianping; Dai, Hong; Wang, Feng; Zhao, Mingwei; Mao, Junfeng; Li, Chaopeng; He, Tao; Pei, Cheng; Liu, Xiaoling; Wang, Xian; Li, Mingxin; Wang, Wei; Zheng, Qinxiang; Guan, Huaijin; Peng, Hui; Fan, Ke; Zhang, Wenfang; Zhu, Dan; Yu, Songping; Wei, Wenbin; Ding, Lin; Li, Jinying; Lu, Peirong; Yan, Ming; Liu, Wei; Jia, Huixun; Sun, Xiaodong .png)
Share.png)
SaveA promising strategy for ocular noninvasive protein delivery: The case in treating corneal neovascularizationMao, BX; Tang, BJ; Yu, SP; Ying, J; Wu, J; Lan, LA; Wang, YF; Zan, XJ; Zheng, QX; Li, J Share Save Share Save Share Save Share Save Share Save Share Save Share Save Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
